DMKJ
PTGX icon

David M. Knott Jr’s Protagonist Therapeutics PTGX Stock Holding History

David M. Knott Jr’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.64M Sell
63,000
-10,000
-14% -$885K 3.95% 5
2025
Q4 		$6.38M Sell
73,000
-10,000
-12% -$818K 2.95% 8
2025
Q3 		$5.51M Buy
83,000
+3,000
+4% +$171K 2.31% 11
2025
Q2 		$4.42M Buy
80,000
+4,000
+5% +$192K 2% 9
2025
Q1 		$3.68M Buy
76,000
+23,632
+45% +$990K 1.73% 12
2024
Q4 		$2.02M Hold
52,368
– – 0.73% 21
2024
Q3 		$2.36M Hold
52,368
– – 0.83% 29
2024
Q2 		$1.81M Hold
52,368
– – 0.72% 30
2024
Q1 		$1.51M Hold
52,368
– – 0.54% 35
2023
Q4 		$1.2M Hold
52,368
– – 0.46% 30
2023
Q3 		$873K Buy
+52,368
New +$1.02M 0.33% 41

Other funds holding PTGX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return